Cannara Biotech, Inc. (LOVE.V)
1.86
-0.02
(-1.06%)
CAD |
TSXV |
Feb 11, 16:00
Cannara Biotech Shareholders Equity (Quarterly) : 111.21M for Nov. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Medexus Pharmaceuticals, Inc. | 72.93M |
| Theralase Technologies, Inc. | 1.093M |
| Cronos Group, Inc. | 1.506B |
| Auxly Cannabis Group, Inc. | 172.52M |
| Organigram Global, Inc. | 369.46M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 173.84M |
| Total Liabilities (Quarterly) | 62.63M |
| Debt to Equity Ratio | 0.3129 |
| Current Ratio | 2.700 |
| Net Debt Paydown Yield | 1.69% |